Market Cap 210.19M
Revenue (ttm) 185.83M
Net Income (ttm) -19.50M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -10.49%
Debt to Equity Ratio 0.00
Volume 847,900
Avg Vol 680,076
Day's Range N/A - N/A
Shares Out 74.80M
Stochastic %K 36%
Beta 0.43
Analysts Sell
Price Target $6.00

Company Profile

OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, sells, and distributes diagnostic products, specimen collection devices, and other diagnostic products in the United States, Europe, Africa, and internationally. The company's products include OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test and self-test, Syphilis health check rapid diagnostic test, OraQuick Ebola rapid antigen test, InteliSwab...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 610 882 1820
Address:
220 East First Street, Bethlehem, United States
ExpectMuse
ExpectMuse May. 21 at 7:58 PM
$OSUR I've been using a new tool that's been quite helpful for active trading. It monitors price movements and sends real-time alerts when a stock starts showing activity - like breaking key levels or seeing a spike in volume. It's designed to catch momentum early, often before it becomes widely noticed. The layout is clean and focused - no extra noise. You can filter by sector or theme, and the alerts come through quickly, which can make a difference in fast-moving markets. If you're trading regularly, it's worth checking out. It doesn't overwhelm your screen, but it’s been useful when things start to move
0 · Reply
john_iii
john_iii May. 21 at 9:36 AM
$OSUR DiluSure files 300M mixed securities shelf.
1 · Reply
Thestocktraderhubzee
Thestocktraderhubzee May. 19 at 3:43 PM
$OSUR Evercore ISI Group Maintains In-Line on OraSure Technologies, Maintains $3 Price Target
0 · Reply
CHItraders
CHItraders May. 19 at 3:39 PM
$OSUR Evercore ISI Says OSUR Has Previously Disclosed That REGN Is Already An Existing Customer, Which Should Bode Well For A Continued Relationship Between OSUR And 23&Me; We Estimate That 23andMe Was A ~$13M Customer For OSUR In 2024
0 · Reply
deepthinker
deepthinker May. 8 at 2:17 PM
$OSUR I said they should buy TRIB. High margin, growth products, synergies, CGM coming to market, molecular diagnostics, HIV market share. But, what do I know.
1 · Reply
HyperBulls
HyperBulls Apr. 22 at 1:33 PM
$INBS @HorseShaq19 It is likely that we will see a company acquisition or merger as you mentioned. Potential is hugeee $ABT Abbott Laboratories (ABT) Revenue: ~$40.1 billion (total), diagnostics segment ~$10 billion (including drug testing) Test Types: Urine, saliva (via Alere brand) $DGX Quest Diagnostics (DGX) Revenue: ~$9.3 billion (drug testing services ~20-25%) Test Types: Urine, blood, hair, saliva $OSUR OraSure Technologies (OSUR) Revenue: ~$400 million Test Types: Saliva (oral fluid test kits) $PMD Psychemedics Corporation (PMD) Revenue: ~$50 million Test Types: Hair Intelligent Bio Solutions (INBS) Revenue: ~$0.61 million Test Types: Fingerprint sweat (non-invasive)
0 · Reply
Richapeslayer_pounce
Richapeslayer_pounce Apr. 21 at 7:09 PM
$OSUR Hit support expect a bounce here and with the market bouncing 👌
0 · Reply
Richapeslayer_pounce
Richapeslayer_pounce Apr. 21 at 7:08 PM
$OSUR Brought some more here market is about to bounce , really like the insider trading something is brewing.
0 · Reply
deepthinker
deepthinker Apr. 16 at 2:19 PM
$OSUR This is a situation where they’ll either be the hunter or the hunted. Just going on collecting salaries and board fees, and buying back stock, isn’t going to work.
0 · Reply
deepthinker
deepthinker Apr. 10 at 3:34 PM
$OSUR They should bid for $TRIB instead of pointlessly buying back their own stock. No brainer.
0 · Reply
Latest News on OSUR
Orasure Technologies: Multiple Shots To Deliver Value

May 28, 2025, 10:25 AM EDT - 21 days ago

Orasure Technologies: Multiple Shots To Deliver Value


OraSure Technologies: Historically Cheap

Apr 30, 2025, 3:47 PM EDT - 7 weeks ago

OraSure Technologies: Historically Cheap


OraSure Announces $40 Million Stock Repurchase Program

Mar 24, 2025, 7:30 AM EDT - 3 months ago

OraSure Announces $40 Million Stock Repurchase Program


OraSure to Present at the J.P Morgan Healthcare Conference

Jan 7, 2025, 4:05 PM EST - 5 months ago

OraSure to Present at the J.P Morgan Healthcare Conference


OraQuick® HIV Self-Test Now Approved for Use in Adolescents

Jan 7, 2025, 7:05 AM EST - 5 months ago

OraQuick® HIV Self-Test Now Approved for Use in Adolescents


OraSure Technologies Acquires Sherlock Biosciences

Dec 19, 2024, 4:02 PM EST - 6 months ago

OraSure Technologies Acquires Sherlock Biosciences


OraSure to Participate in Upcoming Investor Conference

Nov 18, 2024, 4:05 PM EST - 7 months ago

OraSure to Participate in Upcoming Investor Conference


OraSure Reports Q3 '24 Revenue of $39.9 Million

Nov 6, 2024, 4:05 PM EST - 8 months ago

OraSure Reports Q3 '24 Revenue of $39.9 Million


OraSure: An NCAV Diamond In The COVID Rough

Nov 4, 2024, 9:32 AM EST - 8 months ago

OraSure: An NCAV Diamond In The COVID Rough


OraSure Technologies Elects Jack Kenny to the Board of Directors

Sep 9, 2024, 7:05 AM EDT - 10 months ago

OraSure Technologies Elects Jack Kenny to the Board of Directors


OraSure Technologies Inc (OSUR) Q2 2024 Earnings Call Transcript

Aug 6, 2024, 9:04 PM EDT - 11 months ago

OraSure Technologies Inc (OSUR) Q2 2024 Earnings Call Transcript


OraSure Technologies Supports National HIV Testing Day

Jun 27, 2024, 7:05 AM EDT - 1 year ago

OraSure Technologies Supports National HIV Testing Day


OraSure Reports Q4 ‘23 Revenue of $75.9 Million

Feb 27, 2024, 4:05 PM EST - 1 year ago

OraSure Reports Q4 ‘23 Revenue of $75.9 Million


OraSure to Participate in Upcoming Investor Conferences

Nov 13, 2023, 4:15 PM EST - 1 year ago

OraSure to Participate in Upcoming Investor Conferences


OraSure: Valuation Upside On The Table At 16x Forward P/E

May 17, 2023, 5:47 AM EDT - 2 years ago

OraSure: Valuation Upside On The Table At 16x Forward P/E


OraSure Technologies: As Good As It Gets

May 15, 2023, 5:57 PM EDT - 2 years ago

OraSure Technologies: As Good As It Gets


March Madness: My Final 4 Small Cap Stocks Under $10

Mar 13, 2023, 6:00 AM EDT - 2 years ago

March Madness: My Final 4 Small Cap Stocks Under $10

IMMR PAYO


OraSure: Revising To Buy Following Extensive Growth Route

Feb 28, 2023, 10:47 AM EST - 2 years ago

OraSure: Revising To Buy Following Extensive Growth Route


OraSure: Concentration Risk From Covid Revenue, Reaffirm Hold

Nov 30, 2022, 7:12 PM EST - 2 years ago

OraSure: Concentration Risk From Covid Revenue, Reaffirm Hold


ExpectMuse
ExpectMuse May. 21 at 7:58 PM
$OSUR I've been using a new tool that's been quite helpful for active trading. It monitors price movements and sends real-time alerts when a stock starts showing activity - like breaking key levels or seeing a spike in volume. It's designed to catch momentum early, often before it becomes widely noticed. The layout is clean and focused - no extra noise. You can filter by sector or theme, and the alerts come through quickly, which can make a difference in fast-moving markets. If you're trading regularly, it's worth checking out. It doesn't overwhelm your screen, but it’s been useful when things start to move
0 · Reply
john_iii
john_iii May. 21 at 9:36 AM
$OSUR DiluSure files 300M mixed securities shelf.
1 · Reply
Thestocktraderhubzee
Thestocktraderhubzee May. 19 at 3:43 PM
$OSUR Evercore ISI Group Maintains In-Line on OraSure Technologies, Maintains $3 Price Target
0 · Reply
CHItraders
CHItraders May. 19 at 3:39 PM
$OSUR Evercore ISI Says OSUR Has Previously Disclosed That REGN Is Already An Existing Customer, Which Should Bode Well For A Continued Relationship Between OSUR And 23&Me; We Estimate That 23andMe Was A ~$13M Customer For OSUR In 2024
0 · Reply
deepthinker
deepthinker May. 8 at 2:17 PM
$OSUR I said they should buy TRIB. High margin, growth products, synergies, CGM coming to market, molecular diagnostics, HIV market share. But, what do I know.
1 · Reply
HyperBulls
HyperBulls Apr. 22 at 1:33 PM
$INBS @HorseShaq19 It is likely that we will see a company acquisition or merger as you mentioned. Potential is hugeee $ABT Abbott Laboratories (ABT) Revenue: ~$40.1 billion (total), diagnostics segment ~$10 billion (including drug testing) Test Types: Urine, saliva (via Alere brand) $DGX Quest Diagnostics (DGX) Revenue: ~$9.3 billion (drug testing services ~20-25%) Test Types: Urine, blood, hair, saliva $OSUR OraSure Technologies (OSUR) Revenue: ~$400 million Test Types: Saliva (oral fluid test kits) $PMD Psychemedics Corporation (PMD) Revenue: ~$50 million Test Types: Hair Intelligent Bio Solutions (INBS) Revenue: ~$0.61 million Test Types: Fingerprint sweat (non-invasive)
0 · Reply
Richapeslayer_pounce
Richapeslayer_pounce Apr. 21 at 7:09 PM
$OSUR Hit support expect a bounce here and with the market bouncing 👌
0 · Reply
Richapeslayer_pounce
Richapeslayer_pounce Apr. 21 at 7:08 PM
$OSUR Brought some more here market is about to bounce , really like the insider trading something is brewing.
0 · Reply
deepthinker
deepthinker Apr. 16 at 2:19 PM
$OSUR This is a situation where they’ll either be the hunter or the hunted. Just going on collecting salaries and board fees, and buying back stock, isn’t going to work.
0 · Reply
deepthinker
deepthinker Apr. 10 at 3:34 PM
$OSUR They should bid for $TRIB instead of pointlessly buying back their own stock. No brainer.
0 · Reply
NVDAMillionaire
NVDAMillionaire Mar. 27 at 8:38 PM
$OSUR Digging OSUR's strategic pivot. Sherlock Biosciences acquisition looks promising for molecular diagnostics. Core business showing resilience despite COVID test decline. Watching closely for Q1 performance and margin expansion potential. informative article: https://beyondspx.com/article/osur-a-diversified-diagnostics-leader-poised-for-sustainable-growth
0 · Reply
Ahi_Mauna
Ahi_Mauna Mar. 24 at 5:49 PM
$OSUR I should always read more before getting into these stocks. Seemed like good news until I read further down. The repurchase program may be modified, suspended, or discontinued at any time at the Company’s discretion without prior notice.
0 · Reply
Changeisgoodforyou
Changeisgoodforyou Mar. 24 at 2:25 PM
$OSUR I don’t believe I bought this boring stock
0 · Reply
AVCTQBNAPL
AVCTQBNAPL Mar. 24 at 11:45 AM
$OSUR 🚀🚀🚀🚀 https://finance.yahoo.com/news/orasure-announces-40-million-stock-113000183.html
0 · Reply
DonCorleone77
DonCorleone77 Mar. 24 at 11:39 AM
$OSUR OraSure board authorizes $40M stock repurchase program OraSure Technologies announced that its Board of Directors has authorized the repurchase of up to $40 million of its common stock over the next twenty-four months, which will be funded from cash on hand.
0 · Reply
d_risk
d_risk Mar. 7 at 10:22 PM
$OSUR - OraSure Technologies Inc. Common Stock - 10K - Updated Risk Factors OSUR's 2025 10-K Risk Factors highlight new risks from government funding, AI technologies, geopolitical tensions, and regulatory challenges, alongside intensified competition, cybersecurity threats, and the impact of recent acquisitions on revenue growth. #Risk https://d-risk.ai/OSUR/10-K/2025-03-07
0 · Reply
InsiderPeek
InsiderPeek Mar. 3 at 10:33 PM
$OSUR CEO Eglinton Manner Carrie bought 28.7k shares for $100K (ownership up 2.28%) insiderpeek.com/company/OSUR
0 · Reply
CEOBuysDisclosures
CEOBuysDisclosures Mar. 3 at 4:10 PM
$OSUR CEO purchased 28,670 shares at $3.49 for a total of $100,027. EGLINTON MANNER CARRIE now owns 1,288,334 shares. https://ceo-buys.com
0 · Reply
redrussian
redrussian Feb. 28 at 12:04 PM
$RCUS 10.04 pre market $OSUR 3.15 pre market $TALK 2.75
1 · Reply
NewsTrader_perform4nce
NewsTrader_perform4nce Feb. 28 at 9:01 AM
$OSUR BREAKING Huge insider purchases at OraSure Tecnologies These are insider purchases that often bring about a turnaround in the stock. I'm getting in here. ✅ 600k insider purchase ✅ several insiders ✅ Smallcap company (280m market cap.) ✅ Medical Devices sector ✅ Stock at 52 week low ✅ there have been no insider purchases for a long time That's exactly what I want to see --- BREAKING: New Insider Purchases The CEO, CFO, and 2 Directors of $OSUR have all reported purchases of the company's stock, ~$600K in total. These are the first insider purchases at the medical device company in almost two years, and there have been no recent sales. --- Not investment advice. Just my point of view. I could be completely wrong. Insider purchases are no guarantee of rising prices. Stocks have a risk of total loss.
1 · Reply
NewsTrader_perform4nce
NewsTrader_perform4nce Feb. 28 at 5:47 AM
$OSUR Huge Insider buy at a smallcap medtech device company at a 52 week low. I like this kind of insiderbuys. Could be a turning point. --- 🚨BREAKING: New Insider Purchases The CEO, CFO, and 2 Directors of $OSUR have all reported purchases of the company's stock, ~$600K in total. These are the first insider purchases at the medical device company in almost two years, and there have been no recent sales.
0 · Reply
CEOBuysDisclosures
CEOBuysDisclosures Feb. 28 at 4:20 AM
$OSUR CEO purchased 78,625 shares at $3.15 for a total of $247,378. EGLINTON MANNER CARRIE now owns 1,259,664 shares. https://ceo-buys.com
2 · Reply